2m 2m 2m 2m 2m 2m 2m
SURROZEN (SRZN)
NASDAQ
$24.60+$0.03 (+0.12%)
Price as of Jun 03, 2026 4:10 PM EDT- $304.3MMarket Cap
- 195.67%1-Year Change
- BiotechnologyIndustry
SURROZEN (SRZN)
$24.60+$0.03 (+0.12%)
SRZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.57 | ||
Change | +$1.43 (+6.16%) | ||
Open | $23.22 | ||
High | $24.86 | ||
Low | $23.17 | ||
Previous Close | $23.14 | ||
Volume | 78,357 | ||
30-Day Average Volume | 95,548 | ||
1-Week Change | -7.14% | ||
1-Month Change | -26.87% | ||
1-Year Change | 195.67% | ||
3-Year Change | 157.67% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $120.7M | ||
Market Cap | $304.3M | ||
Enterprise Value | $197.4M | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | -$127.5M | ||
Free Cash Flow | -$12.6M | ||
EBIT | -$127.5M | ||
EBITDA | -$127.4M | ||
Net Working Capital | $104.4M | ||
EPS | -$11.65 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 39 | ||
P/B | -1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/14/2023 | ||
Earnings & Revenue